{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:07:59Z","timestamp":1753891679611,"version":"3.41.2"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T00:00:00Z","timestamp":1631232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671132","81471180","82071286"],"award-info":[{"award-number":["81671132","81471180","82071286"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold>Multiple system atrophy (MSA) is a serious neurodegenerative disease that is charactered by progressive neurological disability. The aim of this study was to investigate the correlation of serum oxidant factors with the severity of MSA.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold>A total of 52 MSA patients and 52 age- and gender- matched healthy subjects were retrospectively enrolled in this study. Enzymatic colorimetric methods were used to assay the concentrations of uric acid (UA), serum creatinine (Scr), blood urea nitrogen (BUN), and cystatin C (Cys-C). Disease severity was evaluated by the Unified Multiple System Atrophy Rating Scale (UMSARS). The disease progression rate was defined by the change in UMSARS-IV (global disability score, GDS) over a 1-year period.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold>Comparisons between the two groups revealed that there were no significant differences in terms of serum Scr (70.81 \u00b1 13.88 vs. 70.92 \u00b1 14.19 \u03bcmol\/L,<jats:italic>p<\/jats:italic>= 0.967). However, the serum levels of the other three biomarkers were significantly higher in the MSA patients (UA: 325.31 \u00b1 84.92 vs. 291.19 \u00b1 64.14 \u03bcmol\/L,<jats:italic>p<\/jats:italic>= 0.023; BUN: 5.68 \u00b1 1.67 vs. 4.60 \u00b1 1.24 mmol\/L,<jats:italic>p<\/jats:italic>&amp;lt; 0.001; Cys-C: 0.96 \u00b1 0.15 vs. 0.89 \u00b1 0.14 mg\/L,<jats:italic>p<\/jats:italic>= 0.024). In addition, Pearson correlation analyses revealed that only serum Cys-C was significantly correlated to GDS (<jats:italic>r<\/jats:italic>= 0.281,<jats:italic>p<\/jats:italic>= 0.044). Subgroup analysis further demonstrated that serum Cys-C was the only factor that was positively associated with the disease severity in patients with MSA and predominant cerebellar ataxia (MSA-C) (<jats:italic>r<\/jats:italic>= 0.444,<jats:italic>p<\/jats:italic>= 0.018); there was no significant association in MSA patients with predominant Parkinsonism (MSA-P) (<jats:italic>r<\/jats:italic>= 0.118,<jats:italic>p<\/jats:italic>= 0.582). MSA-C patients with severe disability were shown to express higher serum levels of Cys-C than patients with mild disability (1.03 \u00b1 0.13 vs. 0.88 \u00b1 0.12 mg\/L,<jats:italic>p<\/jats:italic>= 0.009). Finally, Kaplan-Meier plots revealed a significant difference in the 5-year probability of survival from severe disability between MSA-C patients with high- and low-concentrations of serum Cys-C (Log-rank test: X<jats:sup>2<\/jats:sup>= 4.154,<jats:italic>p<\/jats:italic>= 0.042). ROC curve analysis confirmed that serum Cys-C exhibits good performance as a biomarker (AUC = 0.847).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold>Our research indicated that oxidative stress plays a vital role in MSA. Serum Cys-C represents a potential prognostic biomarker to evaluate the severity of disease in patients with MSA-C.<\/jats:p>","DOI":"10.3389\/fnins.2021.663980","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T05:05:10Z","timestamp":1631250310000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Serum Cystatin C as a Potential Predictor of the Severity of Multiple System Atrophy With Predominant Cerebellar Ataxia: A Case-Control Study in Chinese Population"],"prefix":"10.3389","volume":"15","author":[{"given":"Fei","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianzhu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenli","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/978-1-60327-029-8_17","article-title":"Redox homeostasis and cellular stress response in aging and neurodegeneration.","volume":"610","author":"Calabrese","year":"2010","journal-title":"Methods Mole. Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1179\/1743132815y.0000000095","article-title":"Serum creatinine is associated with the prevalence but not disease progression of multiple system atrophy in Chinese population.","volume":"38","author":"Cao","year":"2016","journal-title":"Neurol. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1007\/s00415-013-7006-z","article-title":"Uric acid is associated with the prevalence but not disease progression of multiple system atrophy in Chinese population.","volume":"260","author":"Cao","year":"2013","journal-title":"J. Neurol."},{"key":"B4","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2015.00247","article-title":"Contra-Directional Expression of Serum Homocysteine and Uric Acid as Important Biomarkers of Multiple System Atrophy Severity: A Cross-Sectional Study.","volume":"9","author":"Chen","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neuroscience.2011.09.044","article-title":"Animal models of multiple system atrophy.","volume":"211","author":"Fernagut","year":"2012","journal-title":"Neuroscience"},{"key":"B6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.clineuro.2017.04.002","article-title":"Serum uric acid level is linked to the disease progression rate in male patients with multiple system atrophy.","volume":"158","author":"Fukae","year":"2017","journal-title":"Clin. Neurol. Neurosurg."},{"key":"B7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2741\/s170","article-title":"Protective mechanisms by cystatin C in neurodegenerative diseases.","volume":"3","author":"Gauthier","year":"2011","journal-title":"Front. Biosci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy.","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00702-020-02158-2","article-title":"Genes to treat excitotoxicity ameliorate the symptoms of the disease in mice models of multiple system atrophy.","volume":"127","author":"Glat","year":"2020","journal-title":"J. Neural Transm."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12661","article-title":"Signs of early cellular dysfunction in multiple system atrophy.","volume":"2020","author":"Herrera-Vaquero","year":"2020","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/wnn.0000000000000100","article-title":"Elevated Cystatin C Levels Are Associated with Cognitive Impairment and Progression of Parkinson Disease.","volume":"29","author":"Hu","year":"2016","journal-title":"Cogn. Behav. Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.2353\/ajpath.2010.100461","article-title":"Cystatin C rescues degenerating neurons in a cystatin B-knockout mouse model of progressive myoclonus epilepsy.","volume":"177","author":"Kaur","year":"2010","journal-title":"Am. J. Pathol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1002\/mds.23556","article-title":"Uric acid as a potential disease modifier in patients with multiple system atrophy.","volume":"26","author":"Lee","year":"2011","journal-title":"Move. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"10868","DOI":"10.1002\/jcp.27929","article-title":"Uric acid and angiotensin II additively promote inflammation and oxidative stress in human proximal tubule cells by activation of toll-like receptor 4.","volume":"234","author":"Milanesi","year":"2019","journal-title":"J. Cell. Phys."},{"key":"B15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1159\/000510219","article-title":"Cystatin C and Risk of Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.","volume":"49","author":"Nair","year":"2020","journal-title":"Dement. Geriatr. Cogn. Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/bf01826052","article-title":"Environmental-occupational risk factors and familial associations in multiple system atrophy: a preliminary investigation.","volume":"1","author":"Nee","year":"1991","journal-title":"Clin. Auton. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/mus.25950","article-title":"Urate levels predict survival in amyotrophic lateral sclerosis: Analysis of the expanded Pooled Resource Open-Access ALS clinical trials database.","volume":"57","author":"Paganoni","year":"2018","journal-title":"Muscle Nerve"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.598","article-title":"Serum uric acid levels in Parkinson\u2019s disease and related disorders.","volume":"7","author":"Sakuta","year":"2016","journal-title":"Brain Behav."},{"key":"B19","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00702-015-1503-4","article-title":"Potential mechanisms for low uric acid in Parkinson disease.","volume":"123","author":"Sampat","year":"2016","journal-title":"J. Neural Trans."},{"key":"B20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/ane.12894","article-title":"Serum cystatin C and anti-N-methyl-D-aspartate receptor encephalitis.","volume":"137","author":"Shu","year":"2018","journal-title":"Acta Neurolog. Scand."},{"key":"B21","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S1474-4422(09)70288-1","article-title":"Multiple system atrophy: an update.","volume":"8","author":"Stefanova","year":"2009","journal-title":"The Lancet. Neurology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s12640-011-9294-3","article-title":"Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model.","volume":"21","author":"Stefanova","year":"2012","journal-title":"Neurotox. Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.ajpath.2013.11.018","article-title":"Cystatin C triggers neuronal degeneration in a model of multiple system atrophy.","volume":"184","author":"Suzuki","year":"2014","journal-title":"Am. J. Pathol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/ane.12134","article-title":"Utility of cystatin C for renal function in amyotrophic lateral sclerosis.","volume":"128","author":"Tetsuka","year":"2013","journal-title":"Acta Neurolog. Scand."},{"key":"B25","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/nan.12134","article-title":"Cystatin C is differentially involved in multiple system atrophy phenotypes.","volume":"41","author":"Urbizu","year":"2015","journal-title":"Neuropathol. Appl. Neurob."},{"key":"B26","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1136\/jnnp-2017-317077","article-title":"Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials.","volume":"89","author":"van Eijk","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"B27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/mds.20303","article-title":"Case-control study of multiple system atrophy.","volume":"20","author":"Vanacore","year":"2005","journal-title":"Move. Dis."},{"key":"B28","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2017.00026","article-title":"Plasma Cystatin C and High-Density Lipoprotein Are Important Biomarkers of Alzheimer\u2019s Disease and Vascular Dementia: A Cross-Sectional Study.","volume":"9","author":"Wang","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/mds.20255","article-title":"Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS).","volume":"19","author":"Wenning","year":"2004","journal-title":"Move. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s10571-016-0430-8","article-title":"Suitable Concentrations of Uric Acid Can Reduce Cell Death in Models of OGD and Cerebral Ischemia-Reperfusion Injury.","volume":"37","author":"Zhang","year":"2017","journal-title":"Cell. Mole. Neurob."},{"key":"B31","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1017\/cjn.2016.261","article-title":"Oxidative Stress and Environmental Exposures are Associated with Multiple System Atrophy in Chinese Patients.","volume":"43","author":"Zhou","year":"2016","journal-title":"Can. J. Neurolog.ci. Le"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2021.663980\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T23:10:08Z","timestamp":1673219408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2021.663980\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,10]]},"references-count":31,"alternative-id":["10.3389\/fnins.2021.663980"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2021.663980","relation":{},"ISSN":["1662-453X"],"issn-type":[{"type":"electronic","value":"1662-453X"}],"subject":[],"published":{"date-parts":[[2021,9,10]]},"article-number":"663980"}}